H.C. Wainwright Assumes Viking Therapeutic (VKTX) at Buy, 'An Underappreciated Microcap'

November 10, 2017 7:17 AM

H.C. Wainwright assumes coverage on Viking Therapeutic (NASDAQ: VKTX) with a Buy rating and a price target of $7.00.Analyst Ed ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found